Literature DB >> 31058685

Discriminative Ability of Montreal Cognitive Assessment Subtests and Items in Racial and Ethnic Minority Groups.

Sadaf Arefi Milani1, Michael Marsiske2, Catherine W Striley3.   

Abstract

INTRODUCTION: The Montreal Cognitive Assessment (MoCA) is a popular screening tool for Mild Cognitive Impairment (MCI). The psychometric properties of the MoCA have not been widely examined in minority groups. We aimed to analyze the discriminate ability of subtests and items by race and ethnicity given gold-standard clinical diagnosis of cognitive status.
METHODS: We analyzed data from the National Alzheimer Coordinating Center Uniform Data Set March 2018 data freeze. Stepwise regression was used to determine which subtests predicted cognitive status (normal cognition, MCI, or dementia), by race/ethnicity. Item discrimination and difficulty was calculated by race/ethnicity and cognitive status.
RESULTS: In our sample (n=3895), with an average age of 69.7, 80.7% were non-Hispanic white, 15.0% were non-Hispanic black, and 4.2% were Hispanic. Among non-Hispanic whites all subtests, education, and age predicted clinician diagnosis, while visuospatial/executive, attention, language, delayed recall, and orientation subtests were predictive among non-Hispanic blacks and visuospatial/executive, delayed recall, and orientation subtests and education were predictive among Hispanics. Item discrimination and difficulty varied by race/ethnicity and cognitive status.
CONCLUSIONS: By understanding the psychometric properties of MoCA subtests, we can focus on subtests that have higher discrimination and more diagnostic utility. Subtests should be further evaluated for use in screening of minority individuals.

Entities:  

Mesh:

Year:  2019        PMID: 31058685      PMCID: PMC6710139          DOI: 10.1097/WAD.0000000000000310

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  24 in total

1.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scores.

Authors:  Anne M Damian; Sandra A Jacobson; Joseph G Hentz; Christine M Belden; Holly A Shill; Marwan N Sabbagh; John N Caviness; Charles H Adler
Journal:  Dement Geriatr Cogn Disord       Date:  2011-01-29       Impact factor: 2.959

3.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

4.  An Abbreviated Montreal Cognitive Assessment (MoCA) for Dementia Screening.

Authors:  Daniel K Horton; Linda S Hynan; Laura H Lacritz; Heidi C Rossetti; Myron F Weiner; C Munro Cullum
Journal:  Clin Neuropsychol       Date:  2015-05-15       Impact factor: 3.535

Review 5.  The global prevalence of dementia: a systematic review and metaanalysis.

Authors:  Martin Prince; Renata Bryce; Emiliano Albanese; Anders Wimo; Wagner Ribeiro; Cleusa P Ferri
Journal:  Alzheimers Dement       Date:  2013-01       Impact factor: 21.566

6.  Mild cognitive impairment: a concept in evolution.

Authors:  R C Petersen; B Caracciolo; C Brayne; S Gauthier; V Jelic; L Fratiglioni
Journal:  J Intern Med       Date:  2014-03       Impact factor: 8.989

7.  Validity of the montreal cognitive assessment as a screen for mild cognitive impairment and dementia in African Americans.

Authors:  Felicia C Goldstein; Angela V Ashley; Eric Miller; Olga Alexeeva; Lavezza Zanders; Veronique King
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-03-10       Impact factor: 2.680

8.  Profiles of cognitive subtest impairment in the Montreal Cognitive Assessment (MoCA) in a research cohort with normal Mini-Mental State Examination (MMSE) scores.

Authors:  Arwen Markwick; Giovanna Zamboni; Celeste A de Jager
Journal:  J Clin Exp Neuropsychol       Date:  2012-04-03       Impact factor: 2.475

9.  Montreal Cognitive Assessment Performance among Community-Dwelling African Americans.

Authors:  Heidi C Rossetti; Laura H Lacritz; Linda S Hynan; C Munro Cullum; Aaron Van Wright; Myron F Weiner
Journal:  Arch Clin Neuropsychol       Date:  2017-03-01       Impact factor: 2.813

10.  Optimal cutoffs for the Montreal Cognitive Assessment vary by race and ethnicity.

Authors:  Sadaf Arefi Milani; Michael Marsiske; Linda B Cottler; Xinguang Chen; Catherine W Striley
Journal:  Alzheimers Dement (Amst)       Date:  2018-11-03
View more
  9 in total

Review 1.  Lewy Body Dementias: Controversies and Drug Development.

Authors:  Shannon Y Chiu; Dawn Bowers; Melissa J Armstrong
Journal:  Neurotherapeutics       Date:  2021-12-02       Impact factor: 6.088

2.  Accuracy of Machine Learning Using the Montreal Cognitive Assessment for the Diagnosis of Cognitive Impairment in Parkinson's Disease.

Authors:  Junbeom Jeon; Kiyong Kim; Kyeongmin Baek; Seok Jong Chung; Jeehee Yoon; Yun Joong Kim
Journal:  J Mov Disord       Date:  2022-05-26

Review 3.  The Increase of HIV-1 Infection, Neurocognitive Impairment, and Type 2 Diabetes in The Rio Grande Valley.

Authors:  Roberto De La Garza; Hansapani Rodrigo; Francisco Fernandez; Upal Roy
Journal:  Curr HIV Res       Date:  2019       Impact factor: 1.581

Review 4.  Assessment of Neurocognitive Functions, Olfaction, Taste, Mental, and Psychosocial Health in COVID-19 in Adults: Recommendations for Harmonization of Research and Implications for Clinical Practice.

Authors:  Lucette A Cysique; Emilia Łojek; Theodore Ching-Kong Cheung; Breda Cullen; Anna Rita Egbert; Jonathan Evans; Maite Garolera; Natalia Gawron; Hetta Gouse; Karolina Hansen; Paweł Holas; Sylwia Hyniewska; Ewa Malinowska; Bernice A Marcopulos; Tricia L Merkley; Jose A Muñoz-Moreno; Clare Ramsden; Christian Salas; Sietske A M Sikkes; Ana Rita Silva; Imane Zouhar
Journal:  J Int Neuropsychol Soc       Date:  2021-08-09       Impact factor: 3.114

5.  Bilingualism, assessment language, and the Montreal Cognitive Assessment in Mexican Americans.

Authors:  Emily M Briceño; Roshanak Mehdipanah; Xavier F Gonzales; Steven G Heeringa; Deborah A Levine; Kenneth M Langa; Daniel Zahs; Nelda Garcia; Ruth Longoria; Lewis B Morgenstern
Journal:  J Am Geriatr Soc       Date:  2021-05-07       Impact factor: 7.538

6.  Validity of a novel screen for cognitive impairment and neuropsychiatric symptoms in cardiac rehabilitation.

Authors:  Dana Mohammad; Nathan Herrmann; Mahwesh Saleem; Richard H Swartz; Paul I Oh; Janelle Bradley; Parco Chan; Courtney Ellis; Krista L Lanctôt
Journal:  BMC Geriatr       Date:  2019-06-11       Impact factor: 3.921

7.  Normative and Equated Data of the Original and Basic Versions of the Montreal Cognitive Assessment among Community Dwelling Saudi Arabians.

Authors:  Taim A Muayqil; Nada K Alamri; Awyshah M Alqahtani; Sarah S Julaidan; Raya Alsuhaibani; Ibrahim Nafisah; Walid A Alkeridy; Bandar N Aljafen; Mohammed H Alanazy
Journal:  Behav Neurol       Date:  2021-01-06       Impact factor: 3.342

8.  Screening for Cognitive Dysfunction Using the Rowland Universal Dementia Assessment Scale in Adults With Sickle Cell Disease.

Authors:  Stéphanie Forté; Florence Blais; Mathias Castonguay; Nafanta Fadiga; Mireille Fortier-St-Pierre; Maryline Couette; Richard Ward; Sébastien Béland; Melanie Cohn; Denis Soulières; Kevin H M Kuo
Journal:  JAMA Netw Open       Date:  2021-05-03

9.  A Spanish Neuropsychological Battery Discriminates Between the Behavioral Variant of Frontotemporal Dementia and Primary Progressive Aphasia in a Colombian Sample.

Authors:  Lina Velilla; Jonathan Hernández; Margarita Giraldo-Chica; Edmarie Guzmán-Vélez; Yakeel Quiroz; Francisco Lopera
Journal:  Front Neurol       Date:  2021-07-05       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.